33 studies found for:    eplerenone | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Eplerenone for Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Intervention: Drug: Eplerenone 50mg
2 Recruiting Eplerenone in HIV Associated Abdominal Fat Accumulation
Condition: HIV
Interventions: Drug: Eplerenone and lifestyle;   Other: placebo and lifestyle
3 Not yet recruiting A Study of the Beneficial Effects of Eplerenone on Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Interventions: Drug: Eplerenone;   Drug: Maltodextrin
4 Recruiting Eplerenone in the Management of Abdominal Aortic Aneurysms
Condition: Aortic Aneurysm, Abdominal
Intervention: Drug: Eplerenone
5 Not yet recruiting Pharmacokinetics of Eplerenone Tablet
Condition: Healthy Volunteers
Interventions: Drug: Eplerenone 25 mg;   Drug: Eplerenone 50 mg;   Drug: Eplerenone 100 mg;   Drug: Eplerenone 50 mg twice a day;   Drug: Eplerenone 25 mg twice a day
6 Recruiting Study of the Effect of Eplerenone on Heart Function in Women Receiving Anthracycline Chemotherapy for Breast Cancer
Condition: Breast Cancer
Intervention: Drug: Eplerenone
7 Recruiting Cardiometabolic Effects of Eplerenone in HIV Infection
Conditions: Cardiac Steatosis;   Hepatic Steatosis
Intervention: Drug: Inspra /Eplerenone
8 Recruiting PHOspholamban RElated CArdiomyopathy STudy - Intervention
Condition: Phospholamban R14del Mutation-related Cardiomyopathy
Intervention: Drug: Eplerenone
9 Recruiting Mineralocorticoid Receptor Antagonism Clinical Evaluation in Atherosclerosis Trial
Condition: Atherosclerosis
Interventions: Drug: Eplerenone;   Drug: Placebo
10 Unknown  CMR to Assess Fibrosis in Cardiomyopathy Using Eplerenone
Condition: Cardiomyopathy
Interventions: Drug: Eplerenone;   Drug: Placebo
11 Unknown  EPLErenone in CsA-Treated Recipients (EpleCsAT): Safety
Conditions: Chronic Kidney Insufficiency;   Kidney Transplantation
Intervention: Drug: Eplerenone
12 Unknown  Eplerenone and Aliskiren Research Targeting Hypertensive Patients With Left Ventricular Hypertrophy
Condition: Hypertensive Left Ventricular Hypertrophy
Interventions: Drug: Aliskiren;   Drug: Eplerenone
13 Not yet recruiting Eplerenone in Patients Undergoing REnal Transplant (EPURE TRANSPLANT)
Condition: End-stage Renal Disease
Interventions: Drug: Eplerenon;   Drug: Placebo
14 Recruiting The EPOCH Study (Eplerenone on Top of ACE Inhibition in Chronic Kidney Disease Patients With Hypertension)
Condition: CKD II-III
Interventions: Drug: Eplerenone;   Drug: Placebo
15 Not yet recruiting Effects of Eplerenone on Cardiovascular Disease in HIV (MIRACLE HIV Study)
Condition: HIV
Interventions: Drug: Eplerenone;   Drug: Placebo;   Behavioral: Lifestyle Modification
16 Recruiting Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Interventions: Drug: Eplerenone;   Drug: Spironolactone
17 Recruiting The Role of Aldosterone on Augmented Exercise Pressor Reflex in Hypertension
Condition: Hypertension
Interventions: Drug: Eplerenone;   Drug: Amlodipine;   Procedure: Microneurography;   Procedure: Rhythmic handgrip exercise;   Procedure: Sustained hand grip;   Procedure: Forearm blood flow;   Procedure: Arm cycling exercise;   Procedure: Cold Pressor test
18 Unknown  Does Aldosterone Cause Hypertension by a Non-Renal Mechanism?
Conditions: Hypertension;   Dialysis;   Hyperaldosteronism
Interventions: Drug: Eplerenone;   Drug: Placebo
19 Unknown  Eplerenone For the Treatment of Chronic Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Intervention: Drug: Eplerenone
20 Recruiting Aldosterone Antagonism and Microvascular Function
Conditions: Abdominal Obesity Metabolic Syndrome;   Insulin Resistance;   Hypertension
Interventions: Drug: Eplerenone;   Other: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-33) Show next page of results    Last Page
Indicates status has not been verified in more than two years